Director, Oncology Global Strategic Insights

 

Work Your Magic with us! Start your next chapter and join EMD Serono.

 

Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Healthcare, Life Science, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and planet. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us.  

 

United As One for Patients, our purpose in Healthcare is to help create, improve and prolong lives. We develop medicines, intelligent devices and innovative technologies in therapeutic areas such as Oncology, Neurology and Fertility. Our teams work together across 6 continents with passion and relentless curiosity in order to help patients at every stage of life. Joining our Healthcare team is becoming part of a diverse, inclusive and flexible working culture, presenting great opportunities for personal development and career advancement across the globe.

 

Your Role:

The Director, Oncology Global Strategic Insights, will act as a primary insight thought partner to specific NPP commercial teams. They are responsible for providing commercial insights and thought partnership to inform key development and investment decisions for our oncology early pipeline assets. This position reports to a Sr. Director, Oncology Global Strategic Insights, who coordinates insights and analytics support for our Immuno-Oncology and NPP portfolio. They will provide objective commercial insights based on an in-depth understanding and analysis of commercial, clinical, and scientific information, and integrate customer insights from the appropriate set of secondary sources, market research, competitive intelligence, and opportunity assessments. They will take a leadership role in defining and executing necessary insights activities (competitive intelligence, analytics, market research, opportunity assessment) required to support pivotal development decisions for our early oncology assets. Their focus will be on key global markets and occasionally integrate select emerging markets. Their primary stakeholders will include the Global Business Franchise New Products Portfolio (NPP) team, the Global Value Demonstration, Market Access & Pricing (GVAP) team, Global Medical Affairs, Global Portfolio Management & Decision Support and select members of the Global Project Team for assigned assets.

 

Specific activities include:

• Research and synthesize information from a variety of secondary sources and colleagues to generate a high-level overview of market insights relevant to the asset MOA, tumors of focus and geographies of interest.
• Generate competitive landscapes at the right level of detail and from appropriate sources, with a focus on core tumors and key MOAs represented in our pipeline indications.
• Build scenarios and future possible competitive landscapes based on evolving and emerging MOAs and competitors, many of which may still be in early development stages.
• For priority assets, assist team members in defining key intelligence topics and questions through cross-functional involvement of marketing, medical and clinical.
• Attend or virtually cover key conference and meetings (ASCO, ESMO, ASCO GI, ASCO GU, World Lung, etc.) for oncology, and help coordinate with other functions (brand teams, medical affairs, clinical) in the ethical collection of competitive intelligence.
• Lead coordination with other functions (brand teams, medical affairs, clinical) in the ethical collection of competitive intelligence; facilitate cross-functional discussions, develop, and manage KITs/KIQs; lead de-briefs and simulations of competitive scenarios that help embed CI insights into brand plans, strategic plans, and other key business documents.
• Prepare in-depth analysis of key competitors' strategies, offering insights to support key developmental decision points and milestones; typical analyses might include competitor study benchmarking, informing clinical study design, relevant endpoints, relevant comparators with a future-looking lens.
• Leverage CI insights into portfolio assessments, strategic plans, and other key business documents
• Develop and maintain annual CI coverage plans and budgets.
• Quantify the potential sales opportunity of assets at various stages of early development (including First-in-Human, Proof-of-Concept, and registrational trial transitions)
• Help identify, evaluate, and purchase global secondary data reports and databases and recommend appropriate use.
• Leverage internal resources and CI agencies to identify and characterize key current and future competitors, predict competitor launch timing